Drug intelligence / Profile preview

VibeX Rapid

Development stage
Unknown
Lead developer
Glaukos
Modality
Classical Binding Small Molecules → Small Molecules, Prodrugs/Conditional Activator Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
Administration
Ophthalmic
01

Overview

VibeX Rapid is a CE‑marked, accelerated corneal cross‑linking riboflavin solution used topically on the de-epithelialized cornea in combination with UVA irradiation (typically via the KXL system) to strengthen corneal collagen in patients with progressive keratoconus or corneal ectasia following refractive surgery.[1][4][6] It is a 0.1% riboflavin (vitamin B2 or riboflavin‑5‑phosphate) ophthalmic formulation in saline with hydroxypropyl methylcellulose (HPMC) and no dextran, designed to enhance diffusion into the corneal stroma, reduce procedure soak time, and limit corneal thinning during epithelium‑off cross‑linking.[1][5][6] As a photosensitizer, riboflavin absorbs UVA light and generates reactive oxygen species that induce covalent cross‑links between stromal collagen fibers, increasing corneal biomechanical stability and helping to halt ectatic progression rather than directly improving vision.

Brand names
VibeX Rapid

Beyond the preview

Go deeper on VibeX Rapid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on VibeX Rapid.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call